Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis
- PMID: 17609743
- DOI: 10.1358/mf.2007.29.4.1075358
Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis
Abstract
In humans, phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, reproduces a schizophrenia-like psychosis including positive symptoms, negative symptoms and cognitive dysfunction. Thus, PCP-treated animals have been utilized as an animal model of schizophrenia. PCP-treated animals exhibit hyperlocomotion as an index of positive symptoms, and a social behavioral deficit in a social interaction test and enhanced immobility in a forced swimming test as indices of negative symptoms. They also show a sensorimotor gating deficit and cognitive dysfunctions in several learning and memory tests. Some of these behavioral changes endure after withdrawal from repeated PCP treatment. Furthermore, repeated PCP treatment induces some neurochemical and neuronanatomical changes. Recently, genetic approaches based on "the glutamate hypothesis of schizophrenia" have been used to develop animal models of schizophrenia. NMDA receptor subunit zeta1 knockdown, epsilon1 knockout (KO) and zeta1 point mutant mice exhibiting a hypofunction of NMDA receptors show hyperlocomotion, social behavioral deficit, sensorimotor gating deficit or cognitive dysfunction. Forebrain-specific calcineurin KO, neuregulin 1 heterozygous KO and lysophosphatidic acid 1 receptor KO mice can also serve as animal models of schizophrenia. These findings suggest that PCP and genetic animal models would be useful for evaluating novel therapeutic candidates and for confirming pathological mechanisms of schizophrenia.
(c) 2007 Prous Science. All rights reserved.
Similar articles
-
Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.Neurochem Int. 2007 Jul-Sep;51(2-4):173-84. doi: 10.1016/j.neuint.2007.06.019. Epub 2007 Jun 27. Neurochem Int. 2007. PMID: 17669558 Review.
-
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.Ann N Y Acad Sci. 2006 Nov;1086:160-8. doi: 10.1196/annals.1377.003. Ann N Y Acad Sci. 2006. PMID: 17185514 Review.
-
[Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].Yakugaku Zasshi. 2000 Aug;120(8):677-82. Yakugaku Zasshi. 2000. PMID: 10946617 Japanese.
-
[Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists].Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):47-53. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009. PMID: 19562941 Review. Japanese.
-
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5. Int Rev Neurobiol. 2007. PMID: 17349858 Review.
Cited by
-
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.Psychopharmacology (Berl). 2015 Aug;232(15):2849-61. doi: 10.1007/s00213-015-3920-3. Epub 2015 Apr 15. Psychopharmacology (Berl). 2015. PMID: 25869273
-
Removing obstacles in neuroscience drug discovery: the future path for animal models.Neuropsychopharmacology. 2009 Jan;34(1):74-89. doi: 10.1038/npp.2008.173. Epub 2008 Oct 1. Neuropsychopharmacology. 2009. PMID: 18830240 Free PMC article. Review.
-
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.Eur Neuropsychopharmacol. 2016 Feb;26(2):298-309. doi: 10.1016/j.euroneuro.2015.12.009. Epub 2015 Dec 10. Eur Neuropsychopharmacol. 2016. PMID: 26706691 Free PMC article.
-
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.Schizophr Bull. 2010 Mar;36(2):246-70. doi: 10.1093/schbul/sbp132. Epub 2009 Nov 9. Schizophr Bull. 2010. PMID: 19900963 Free PMC article. Review.
-
Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.Psychopharmacology (Berl). 2009 Sep;206(1):39-49. doi: 10.1007/s00213-009-1578-4. Epub 2009 Jun 9. Psychopharmacology (Berl). 2009. PMID: 19506838
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials